Lori D. Klaman

3.5k total citations · 1 hit paper
22 papers, 3.0k citations indexed

About

Lori D. Klaman is a scholar working on Molecular Biology, Oncology and Physiology. According to data from OpenAlex, Lori D. Klaman has authored 22 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Oncology and 7 papers in Physiology. Recurrent topics in Lori D. Klaman's work include Protein Tyrosine Phosphatases (8 papers), Adipose Tissue and Metabolism (5 papers) and Viral-associated cancers and disorders (5 papers). Lori D. Klaman is often cited by papers focused on Protein Tyrosine Phosphatases (8 papers), Adipose Tissue and Metabolism (5 papers) and Viral-associated cancers and disorders (5 papers). Lori D. Klaman collaborates with scholars based in United States, Canada and Germany. Lori D. Klaman's co-authors include Benjamin G. Neel, Ruth E. Gimeno, Barbara B. Kahn, Odile D. Peroni, Jason K. Kim, Young‐Bum Kim, Janice M. Zabolotny, Gerald I. Shulman, Olivier Boss and Alain Stricker‐Krongrad and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Lori D. Klaman

22 papers receiving 2.9k citations

Hit Papers

Increased Energy Expenditure, Decreased Adiposity, and Ti... 2000 2026 2008 2017 2000 250 500 750 1000

Peers

Lori D. Klaman
Jyotirmoy Kusari United States
Norman J. Kennedy United States
Jessica Schwartz United States
Maofu Fu United States
William Matthews United States
Alexandra L. Brown United States
Jyotirmoy Kusari United States
Lori D. Klaman
Citations per year, relative to Lori D. Klaman Lori D. Klaman (= 1×) peers Jyotirmoy Kusari

Countries citing papers authored by Lori D. Klaman

Since Specialization
Citations

This map shows the geographic impact of Lori D. Klaman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lori D. Klaman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lori D. Klaman more than expected).

Fields of papers citing papers by Lori D. Klaman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lori D. Klaman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lori D. Klaman. The network helps show where Lori D. Klaman may publish in the future.

Co-authorship network of co-authors of Lori D. Klaman

This figure shows the co-authorship network connecting the top 25 collaborators of Lori D. Klaman. A scholar is included among the top collaborators of Lori D. Klaman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lori D. Klaman. Lori D. Klaman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
James, Michael L., Haichen Wang, Viviana Cantillana, et al.. (2012). TT-301 Inhibits Microglial Activation and Improves Outcome after Central Nervous System Injury in Adult Mice. Anesthesiology. 116(6). 1299–1311. 22 indexed citations
2.
Erbe, D.V., Lori D. Klaman, Douglas Wilson, et al.. (2009). Prodrug delivery of novel PTP1B inhibitors to enhance insulin signalling. Diabetes Obesity and Metabolism. 11(6). 579–588. 17 indexed citations
3.
Stolz, Leslie E., et al.. (2006). Administration of myostatin does not alter fat mass in adult mice. Diabetes Obesity and Metabolism. 10(2). 135–142. 31 indexed citations
4.
Yang, Wentian, Lori D. Klaman, Binbin Chen, et al.. (2006). An Shp2/SFK/Ras/Erk Signaling Pathway Controls Trophoblast Stem Cell Survival. Developmental Cell. 10(3). 317–327. 219 indexed citations
5.
Tremblay, Frédéric, Mylène Perreault, Lori D. Klaman, et al.. (2006). Normal Food Intake and Body Weight in Mice Lacking the G Protein-Coupled Receptor GPR39. Endocrinology. 148(2). 501–506. 121 indexed citations
6.
Gimeno, Ruth E. & Lori D. Klaman. (2005). Adipose tissue as an active endocrine organ: recent advances. Current Opinion in Pharmacology. 5(2). 122–128. 145 indexed citations
7.
Erbe, David V., Suyue Wang, Yanling Zhang, et al.. (2004). Ertiprotafib Improves Glycemic Control and Lowers Lipids via Multiple Mechanisms. Molecular Pharmacology. 67(1). 69–77. 75 indexed citations
8.
Kushner, Jake A., Fawaz G. Haj, Lori D. Klaman, et al.. (2004). Islet-Sparing Effects of Protein Tyrosine Phosphatase-1b Deficiency Delays Onset of Diabetes in IRS2 Knockout Mice. Diabetes. 53(1). 61–66. 56 indexed citations
9.
Haj, Fawaz G., Boyka Markova, Lori D. Klaman, Frank D. Böhmer, & Benjamin G. Neel. (2003). Regulation of Receptor Tyrosine Kinase Signaling by Protein Tyrosine Phosphatase-1B. Journal of Biological Chemistry. 278(2). 739–744. 218 indexed citations
10.
Gu, Haihua, Kan Saito, Lori D. Klaman, et al.. (2001). Essential role for Gab2 in the allergic response. Nature. 412(6843). 186–190. 277 indexed citations
11.
Zabolotny, Janice M., Young‐Bum Kim, Odile D. Peroni, et al.. (2001). Overexpression of the LAR (leukocyte antigen-related) protein-tyrosine phosphatase in muscle causes insulin resistance. Proceedings of the National Academy of Sciences. 98(9). 5187–5192. 101 indexed citations
12.
Saito, Kan, Lori D. Klaman, Joanne C. Pratt, et al.. (2001). Gu, H. et al. Essential role for Gab2 in the allergic response. Nature 412, 186-190. 19 indexed citations
13.
Chen, Binbin, Roderick T. Bronson, Lori D. Klaman, et al.. (2000). Mice mutant for Egfr and Shp2 have defective cardiac semilunar valvulogenesis. Nature Genetics. 24(3). 296–299. 214 indexed citations
14.
Klaman, Lori D., Olivier Boss, Odile D. Peroni, et al.. (2000). Increased Energy Expenditure, Decreased Adiposity, and Tissue-Specific Insulin Sensitivity in Protein-Tyrosine Phosphatase 1B-Deficient Mice. Molecular and Cellular Biology. 20(15). 5479–5489. 1057 indexed citations breakdown →
15.
Decker, L L, Lori D. Klaman, & David A. Thorley‐Lawson. (1996). Detection of the latent form of Epstein-Barr virus DNA in the peripheral blood of healthy individuals. Journal of Virology. 70(5). 3286–3289. 145 indexed citations
16.
Mainville, C.A., et al.. (1996). Deletional mapping of fifteen mouse VH gene families reveals a common organization for three Igh haplotypes. The Journal of Immunology. 156(3). 1038–1046. 42 indexed citations
17.
Klaman, Lori D. & David A. Thorley‐Lawson. (1995). Characterization of the CD48 gene demonstrates a positive element that is specific to Epstein-Barr virus-immortalized B-cell lines and contains an essential NF-kappa B site. Journal of Virology. 69(2). 871–881. 17 indexed citations
18.
Thorley‐Lawson, David A., Christopher J. Ianelli, Lori D. Klaman, Donald E. Staunton, & Shinkichi Yokoyama. (1993). Function of CD48 and its regulation by Epstein-Barr virus. Biochemical Society Transactions. 21(4). 976–980. 10 indexed citations
19.
Klaman, Lori D., Elizabeth A. Hurley, & David A. Thorley‐Lawson. (1991). Is there a unique episome in EBV transformed B cells?. Virology. 185(2). 883–887. 5 indexed citations
20.
Ohara, Yoshiro, et al.. (1988). Molecular cloning and sequence determination of DA strain of Theiler's murine encephalomyelitis viruses. Virology. 164(1). 245–255. 113 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026